|
DCUN1D4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.03304040269359E-12 |
| Normal-vs-Stage2 |
3.98549999669484E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
2.25164331624228E-12 |
| Stage1-vs-Stage2 |
1.209190E-01 |
| Stage1-vs-Stage3 |
6.149900E-02 |
| Stage1-vs-Stage4 |
7.206000E-02 |
| Stage2-vs-Stage3 |
9.901500E-03 |
| Stage2-vs-Stage4 |
1.505590E-02 |
| Stage3-vs-Stage4 |
7.284800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63524749297039E-12 |
| Normal-vs-AfricanAmerican |
4.11069999994851E-06 |
| Normal-vs-Asian |
6.09520001138009E-09 |
| Caucasian-vs-AfricanAmerican |
1.928790E-01 |
| Caucasian-vs-Asian |
5.802300E-02 |
| AfricanAmerican-vs-Asian |
9.372000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.22852855560996E-13 |
| Normal-vs-Female |
6.27276008913213E-14 |
| Male-vs-Female |
3.609600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.66622271535743E-12 |
| Normal-vs-Age(81-100Yrs) |
1.682580E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.375400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.102000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.780600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.417000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.058400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.908000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.529600000023E-06 |
| Classical-VS-Follicular |
1.398710E-03 |
| Classical-VS-Other |
3.221400E-01 |
| Classical-VS-Normal |
1.2481127242836E-12 |
| Tall-VS-Follicular |
1.39540001775629E-09 |
| Tall-VS-Other |
4.206300E-02 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
9.375000E-01 |
| Follicular-VS-Normal |
7.15100001436042E-09 |
| Other-VS-Normal |
1.387760E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
2.9029001424874E-10 |
| N0-vs-N1 |
6.298600E-01 |
|
|
